Skip to content

A research on the neural mechanism of ChaiHuShuGan powder in the treatment of cancer related depression

A research on the neural mechanism of ChaiHuShuGan powder in the treatment of cancer related depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001052
Enrollment
Unknown
Registered
2025-05-27
Start date
2022-08-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer-related depression

Interventions

Treatment Groups:ChaiHuShuGan powder

Sponsors

Beijing Hospital of Integranted Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. meet the International Union Against Cancer (IUAC) diagnostic criteria for tumours diagnosed as breast cancer by pathology and/or cytology and hormone receptor (ER/PR) positive patients 2. diagnosed as cancer-related depression according to the co-diagnosis of two physicians (including a psychiatrist) with a score of moderate depression on the Hamilton Depression Rating Scale (HAMD24) 3. Chinese medicine identification in accordance with the Chinese Medicine Symptoms Rating Scale for Depression (HAMD24) liver-depression-spleen-deficiency type 4. Age 45-65 years old postmenopausal female patients5.KPS score = 80 points6.Expected survival > 1 year7.Patients who have completed surgery/radiotherapy/chemotherapy for breast cancer more than 3 months from surgery and radiotherapy and patients during current endocrine agent maintenance therapy8.Voluntary participation in this clinical study and signing of the informed consent form

Exclusion criteria

Exclusion criteria: 1 People with familial hereditary depression 2. Combined severe cardiac hepatic renal dysfunction and haematopoietic disorders 3. Illiterate mentally challenged or psychotic patients 4. Undergoing other clinical trials 5. Incomplete study data

Design outcomes

Primary

MeasureTime frame
brain waves;

Countries

China

Contacts

Public ContactHaiyan Deng

Beijing Hospital of Integrated Traditional Chinese and Western Medicine

denghaiyan.china@163.com13811564413

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026